Regulation

The ACCC’s News Media Bargaining Code: Experimenting with “Decentralized Regulation” of Dominant Digital Platforms

The Australian Competition and Consumer Commission recently proposed a mandatory bargaining code to govern negotiations between digital platforms like Google and Facebook...

Self-Favoring in the Digital Economy and the Role of Antitrust

At the moment, the strategy of the major tech platforms seems to be to deny any bias and malicious self-favoring. The facts,...

Special Interests Hide Behind Regulatory Myths

Three myths about federal regulation help prevent much of the public, and many experts, from realizing how many regulations serve to promote...

The House’s Big Tech Hearing: Break Ups Large and Small?

Last week’s epic House hearing on online platforms raised many issues, chief among which was the question who gets to operate at...

Top 10 Admissions from Tech CEOs Secured at the Antitrust Hearing

This week’s Congressional hearing produced evidence of anticompetitive conduct that state attorneys general and private enforcers can use to pursue the dominant...

More and More Employers Are Spying on Workers Online. Federal Regulators Are Okay With It

Employers today have numerous tools at their disposal to monitor workers’ behavior and communications. Outdated federal regulations and an administration that prioritizes...

What Congress Should Ask Big Tech CEOs

This week, the House Committee on the Judiciary will hold a hearing on digital platforms and market power, during which members will get...

The EU’s Attempt at Updating Antitrust Market Definition for the Digital Age

The rise of digital platforms has upended markets and the very act of market definition—the basic unit of antitrust analysis. With the...

Was the 2017 FCC Spectrum Auction a Success—or a Disappointing Failure?

In a post published on his company’s website, Stanford professor Paul Milgrom responded to the recent ProMarket pieces by Glen Weyl and...

Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be

New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.

LATEST NEWS

Buchanan’s Samaritan’s Dilemma

The Samaritan’s dilemma is not only about the detrimental effects help can have on the beneficiaries. As James Buchanan explained in his...

How Will the FTC Evaluate Vertical Mergers?

The Federal Trade Commission’s recent withdrawal of its 2020 vertical merger guidelines is flatly incorrect as a matter of microeconomic theory and...

Announcing the Participants in the Fall 2021 Stigler Center Journalists in Residence Program

This month, the Stigler Center will welcome eight world-class journalists from the United Kingdom, Brazil, China, Romania, Ukraine, Slovenia, and the United...

The Roots of America’s Competition Revolution

Proponents of the current transformation in America’s competition policy managed to shape legislative reform proposals, push public antitrust agencies to boost enforcement, and successfully...

Looks Can Be Deceiving: Ronald Coase and the Chicago School

Ronald Coase is typically thought of as one of the Chicago School’s brightest lights. But Coase’s relationship with Chicago was always an...